Board summary
Key figures
43,728
Registered population
65.1% aged 18–64
13.9%
Aged 65+
ICB 18.8% · England 17.9%
27.0%
Ethnic minority (non-White)
20.9% Asian · England 9.6%
1.6%
In IMD quintile 1
ICB 0.8% · England 21.0%
~630
Core20 residents (est.)
Resident basis; registered basis ~655 · see page 3
5,304
Hypertension register
+5.67% in 3 yrs · England +5.60%
370
SMI register
36.8% of Woking's
489
COPD register
Reviews +0.62% in 3 yrs
Forecast to 2030
6,535
Hypertension patients, 2030
+1,231 on today
72.1%
QRISK ≥20% on statins, 2030
+3.40pp over 3 yrs
3.8%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Seventeen of twenty-five three-year trends trail England.
Non-frail diabetes HbA1c control fell 0.6% (England +4.4%) and mental health BMI recording rose +1.4 pp (England +5.1 pp), which may warrant recall review.
Pre-school booster coverage sits below 95.0% target.
MMR dose 2 is 85.6% (below the 95.0% target by 9.4 pp) and 4-in-1 is 82.2%, which may reflect unverified recall gaps.
Strong clinical delivery on existing disease registers.
Hypertension target control is 73.1% (England 70.3%) and asthma reviews reach 69.5% (England 65.7%), though recorded hypertension prevalence is 12.0% (England 15.2%).
Population, age and ethnicity
A younger population with 20.9% Asian residents alongside 36.8% of Woking's mental illness register
Across four constituent practices, WOKING WISE 2 PCN serves 43,728 registered patients. Only 13.9% (6,062 patients) are aged 65+ (Woking 15.3%, NHS Surrey Heartlands Integrated Care Board 18.8%, England 17.9%), while 65.1% are aged 18-64 (28,475 patients; Woking 63.4%, ICB 60.8%, England 62.7%) and 21.0% aged 0-17 (9,191 patients; Woking 21.3%, ICB 20.4%, England 19.6%). In the resident catchment, 20.9% are Asian or Asian British (Woking 14.2%, ICB 7.7%, England 9.6%), reaching 28.4% at Maybury Surgery. These ethnic proportions reflect Census usual residents rather than GP-registered patients.
Age profile
65+: ICB 18.8%, England 17.9%
Ethnicity
Older people · falls rows are Woking local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Woking LA) | 1,854 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 82.0% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 57.7% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Woking LA) | 796 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Woking LA) | 11.2 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Deprivation is low overall, with Core20 patients concentrated at Sunny Meed Surgery
Woking Wise 2 PCN has low relative deprivation with an average IMD decile of 7.2 (Woking 7.8, NHS Surrey Heartlands Integrated Care Board 7.9, England 5.5). Registered Core20 prevalence is 1.6% (Woking 1.5%, NHS Surrey Heartlands Integrated Care Board 0.8%, England 21.0%), though weighted practice rates reconcile to 1.5%. Deprivation concentrates in Sunny Meed Surgery (2.2% share; 322 estimated patients) and Hillview Medical Centre (1.2% share; 182 estimated patients). Proactive Core20 outreach can focus on these two practices where local deprivation and estimated patient volume concentrate.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
370
SMI register
0.84% recorded prevalence
236
Learning disability register
0.53% recorded prevalence
17
Care homes, 571 beds
In the PCN catchment
8.3%
Provide unpaid care
Woking, Census 2021
Severe mental illness prevalence is 0.8% (370 patients; Woking 0.8%, NHS Surrey Heartlands Integrated Care Board 0.8%, England 1.0%) and learning disability is 0.5% (236 patients; Woking 0.5%, ICB 0.5%, England 0.6%), representing 36.8% and 38.4% of Woking's registers. Catchment care homes total 17 with 571 beds. The network holds over a third of Woking's recorded severe mental illness and learning disability patients.
Severe mental illness: physical health checks
Recorded SMI blood pressure checks reached 81.9% (England 83.4%), while BMI checks reached 82.2% (England 82.1%). Three-year BMI check growth of +1.4 pp trailed England (+5.1 pp). Complete annual health checks were not captured.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
5,304
Hypertension register
+5.67%
Register growth, 3 yrs
Woking +6.51% · England +5.60%
+2.05pp
BP control, under 80
≤140/90 · −0.22pp aged 80+
+1,231
More patients by 2030
Forecast 6,535 (13.40%)
Hypertension case-finding and control
Recorded hypertension prevalence is 12.0% (5,304 patients), trailing Woking (13.2%), NHS Surrey Heartlands ICB (14.3%), and England (15.2%), with an unadjusted register gap range of +477 to +1,356 patients. Slower prevalence may reflect a younger list (13.9% aged 65+ versus 17.9% in England). Among diagnosed patients, clinical management is strong: 92.3% had a recent blood pressure reading (England 90.0%) and 73.1% are treated to target (England 70.3%), although control in patients aged 80 and over fell 0.3% over three years (England +2.2%). Lower recorded prevalence than England may reflect demographic differences or unverified detection gaps, which age-stratified audits could test.
Lipids and statins
Patients with QRISK ≥ 20% on lipid-lowering therapy reach 64.7%, exceeding England (63.6%), Woking (61.7%), and NHS Surrey Heartlands ICB (59.4%). Statin therapy for diabetes without cardiovascular disease is 70.0%, below England (73.2%). Lower diabetic statin therapy than England indicates an opportunity to review recall for eligible patients.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 41,588 | £2.10 | £2.24 | £1.86 | £87,335 |
| Cardiovascular (all), 2025 | 55,781 | £5.22 | £4.74 | £3.33 | £291,177 |
In 2026, lipid-modifying drugs cost £2.10 per item across 41,588 items (£87,335 spend), compared with £1.86 in England, £2.50 in Woking, and £2.24 in NHS Surrey Heartlands ICB, spending £9,981 more than at England's unit cost. This unit-cost indicator does not account for case-mix or formulary choices, but highlights an area for local prescribing review.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+5.65%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
−1.01%
Asthma prevalence, PCN 3-yr % change
Recorded COPD prevalence is 1.1% (489 patients), trailing England (1.9%), Woking (1.2%), and NHS Surrey Heartlands ICB (1.3%), and fell 0.6% over three years (England +2.6%). Asthma prevalence is 5.3% (2,179 patients; England 6.6%), having fallen 1.0% over three years (England +0.5%). Conversely, 12-month review rates exceed national benchmarks: COPD reviews reached 78.9% (England 76.4%) and asthma reviews reached 69.5% (England 65.7%), leaving an estimated 664 asthma patients unreviewed. Contracting registers alongside high review rates could reflect unverified coding attrition, testable by clinical audit.
Cancer register and children's immunisation
Cancer prevalence is 3.4% (1,487 patients; England 3.8%). Childhood immunisation shows strong early uptake, with 6-in-1 reaching 96.6% at 24 months, above the 95.0% target. By age five, coverage falls below target: MMR dose 2 is 85.6% (9.4 pp below the 95.0% target) and the 4-in-1 booster is 82.2% (12.8 pp below target), showing a 5.9 pp MMR dose difference.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
61.4%
Surrey Heartlands ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~650
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Surrey Heartlands ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 65.7% | 53.2% | 18% | 1,044 |
| Breast | 88.2% | 85.4% | 27% | 798 |
| Bowel | 48.1% | 47.0% | 18% | 626 |
| Lung | 33.2% | 33.8% | 17% | 497 |
| Skin cancer | 89.8% | 87.8% | 19% | 384 |
In NHS Surrey Heartlands ICB, 61.4% of cancers with a known stage (2,955 of 4,810) were diagnosed at stage 1 or 2 in 2022, which is 6.1 percentage points above England (55.3%) but 13.6 percentage points below the 75.0% national ambition. Known-stage completeness was 67.7% (4,810 of 7,106 cancers). At PCN level, breast screening coverage is 64.9% (England 69.9%, ICB 71.2%), while cervical screening in women aged 25 to 49 is 67.4% (ICB 69.3%), falling 2.0% over three years (England -1.0%). Practice cervical coverage includes 58.8% at Southview Medical Practice and 60.1% at Maybury Surgery. System staging describes wider performance, not PCN delivery.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
Ashford and St Peter's Hospitals NHS Foundation Trust achieved 76.4% on the 62-day cancer referral to treatment standard in Jul 2026 (provisional), below the 85.0% standard but above England (71.2%) and NHS Surrey and Sussex Integrated Care Board (71.5%), while Royal Surrey NHS Foundation Trust reached 84.5% and Frimley Health NHS Foundation Trust 81.8%. The trust met the 28-day faster diagnosis standard at 85.5% (standard 75.0%). For diagnostics, 6-week waits reached 49.6% for colonoscopy (England 30.8%) and 57.9% for flexi sigmoidoscopy (England 32.1%).
| Pathways within standard (%) | Ashford and St Peter's | Royal Surrey | Frimley Health | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 85.53 | 82.62 | 87.95 | 79.29 | 79.32 |
| 31-day treatment (96%) | 94.21 | 96.43 | 92.89 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 76.38 | 84.48 | 81.84 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Ashford and St Peter's | Royal Surrey | Frimley Health | England |
|---|---|---|---|---|
| MRI | 0.09 | 0.00 | 12.85 | 21.40 |
| CT | 9.27 | 0.15 | 0.63 | 9.92 |
| Echocardiography | 0.97 | 1.55 | 3.35 | 28.48 |
| Colonoscopy | 49.61 | 0.00 | 22.84 | 30.83 |
| Gastroscopy | 56.74 | 0.00 | 7.43 | 29.02 |
| All 15 DM01 tests | 23.12 | 8.82 | 7.49 | 23.14 |
| Community services activity | Surrey residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 109,530 | 309,615 |
| Referrals | 28,700 | 66,930 |
| Patients with a contact | 33,510 | 85,660 |
Community services (residents of Surrey), Jun 2026 (provisional). For Woking borough residents, community health services recorded 109,530 contacts in Jun 2026 (provisional), with adults aged 65 and over accounting for 69.6% (76,215 contacts). Activity is captured at local authority level across NHS Surrey Heartlands Integrated Care Board rather than by PCN, highlighting substantial community-based clinical touchpoints concentrated among older residents.
Practice variation and patient experience
Practice phone access spans 25.6 pp alongside a 23.3 pp spread in vaccination achievement
In 2025/26, overall QOF achievement ranges from 87.1% at Southview Medical Practice to 96.8% at Sunny Meed Surgery (England 92.5%). Vaccination achievement spans 23.3 pp, from 49.9% at Southview Medical Practice to 73.2% at Sunny Meed Surgery (England 55.2%), while personalised care adjustments reach 14.4% at Maybury Surgery.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Maybury Surgery | 93 | 0.0 | 58.9% | 62.0% | 79.1% |
| Southview Medical | 129 | 1.4 | 47.5% | 69.8% | 74.2% |
| Hillview | 99 | 1.2 | 35.9% | 66.0% | 65.8% |
| Sunny Meed Surgery | 110 | 2.2 | 33.3% | 67.8% | 65.0% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
The PCN trails England on 17 of 25 three-year trend measures
WOKING WISE 2 PCN trails England on 17 of 25 three-year trends. The widest lags include non-frail diabetes HbA1c control, recording -0.6% over three years compared to +4.4% in England and +2.2% in Woking, and annual BMI checks for patients on the mental health register, which rose +1.4 pp against +5.1 pp nationally. Conversely, strong areas include psychosis alcohol recording, which rose +8.9 pp (England +5.4 pp), and learning disability register growth of +13.5% (England +5.4%).
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Diabetes HbA1c control
BMI record (SMI)
COPD register
Heart failure reviews
Cancer register
Alcohol record (psychosis)
Diabetes statin (no CVD)
Asthma reviews
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Woking | Asset | PCN | Woking |
|---|---|---|---|---|---|
| Care homes (catchment) | 17 (571 beds) | n/a | Schools (catchment) | 69 | n/a |
| Children's centres | 6 | 8 | Places of worship | 39 | 49 |
| Libraries | n/a | 1 | Homelessness support (VCS) | 0 | no data |
| Day centres (VCS) | 2 | 2 | Carers support groups (VCS) | 1 | 1 |
| Primary schools (LA maintained) | 1 | 2 | Primary academies | 15 | 19 |
| Special schools | 1 | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Pre-school booster recall and catch-up
Age-5 MMR2 coverage is 85.6% (below the 95.0% target by 9.4 pp; ICB 87.0%, England 82.8%) and 4-in-1 is 82.2% (below target by 12.8 pp), with a 5.9 pp MMR dose difference across 118 children. Low cost, quick to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Option 2
Age-stratified hypertension case-finding audit
Recorded hypertension prevalence is 12.0% (5,304 patients) against 13.2% in Woking, 14.3% in ICB, and 15.2% in England, giving an unadjusted gap range of +477 to +1,356 patients. Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 3
Respiratory register validation and asthma recall
COPD prevalence is 1.1% (489 patients vs Woking 1.2%, England 1.9%; unadjusted gap +25 to +339), falling 0.6% over three years; 69.5% asthma review coverage leaves 664 of 2,179 patients unreviewed. Moderate effort to run.
Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.
Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Culturally tailored outreach review (p2) | Asian / Asian British | Neighbourhood health framework · Core20PLUS5 approach | PCN |
| Targeted Core20 practice outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Physical health check recall (p4) | Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs) | MHIS · From Harm to Hope | PCN |
| Hypertension case finding audit (p5) | Hypertension: QOF prevalence | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school booster recall catch-up (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical and breast screening outreach (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Practice phone access review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Pre-school booster recall and catch-up (p12) | MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 | MHIS · From Harm to Hope | PCN |
| Option 2 · Age-stratified hypertension case-finding audit (p12) | Hypertension register · Hypertension: QOF prevalence · Aged 65+ | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Option 3 · Respiratory register validation and asthma recall (p12) | COPD register · COPD: QOF prevalence · Asthma register | Core20PLUS5 respiratory | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
